Klaus, Johannes
Gerhardt, Felix
Nienaber, Stephan
Mauri, Victor
Möllenhoff, Kathrin
Nies, Richard
Kuhn, Elmar
Gerfer, Stephen
Djordjevic, Ilija
Lee, Samuel
Guthoff, Henning
Iliadis, Christos
Baldus, Stephan
Hohmann, Christopher
Adam, Matti
Wienemann, Hendrik https://orcid.org/0000-0001-5810-2868
Funding for this research was provided by:
Universitätsklinikum Köln
Article History
Received: 3 June 2025
Accepted: 11 August 2025
First Online: 22 September 2025
Declarations
:
: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.
: E. Kuhn reports consultancy and personal fees from Medtronic, Edwards Lifesciences, Boston Scientific, and Abbott. S. Baldus reports lecture fees from Abbott, Edwards Lifesciences, AstraZeneca, and JenaValve Technology; he received research grants from Abbott and AstraZeneca; and participates as a principal investigator in clinical trials sponsored by AstraZeneca and Abbott. C. Hohmann reports lecture/consultancy fees and/or travel grants from Bayer, Daiichi Sankyo, Edwards Lifesciences, Johnson & Johnson, MSD, and Pfizer. M. Adam reports grants and personal fees from Medtronic, and personal fees from Abbott, JenaValve Technology, Edwards Lifesciences, Boston Scientific, and Meril. H. Wienemann reports consultancy fees and travel grants from JenaValve Technology. All other authors declare no conflict of interest.